Browse by category

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Semaglutide could also help people cut down on their alcohol intake, according to the findings from the ‘Human Laboratory Screening of...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

A study led by researchers at the University of Nottingham has found that glucagon-like peptide-1 receptor agonists use (GLP-1 RAs) may...

A joint study by the University of Eastern Finland and Karolinska Institutet in Sweden has found that the GLP-1 agonists semaglutide and...

People with opioid or alcohol use disorder (OUD, AUD) who take glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to treat...

Sanford Health researcher, Dr Scott Engel, along with his co-Principal Investigators, Drs Kristine Steffen and Leslie Heinberg (Cleveland...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

The proportion of bariatric surgery patients with alcohol use disorders (AUDs) is concerning, given that alcohol consumption should be...

Patients with obesity who received semaglutide had a 50%-56% lower risk for both the incidence and recurrence of alcohol use disorder...